Loading…
The company will present at the American Society of Hematology 67th Annual Meeting.
Prelude Therapeutics Inc (Nasdaq: PRLD) announced on November 3, 2025, the publication of abstracts for presentation at the American Society of Hematology 67th Annual Meeting.
The company will showcase its research and developments in the biotechnology sector at the event.
This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.